Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma

• Published in: Chinese medicine Vol. 17; no. 1; pp. 1 - 15
• Main Authors: Wei, Lai, Wang, Zeyu, Jing, Niancai, Lu, Yi, Yang, Jili, Xiao, Hongyu, Guo, Huanyu, Sun, Shoukun, Li, Mingjing, Zhao, Daqing, Li, Xiangyan, Qi, Wenxiu, Zhang, Yue
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 30-07-2022; BioMed Central; BMC
• Subjects: 5-Fluorouracil; Ablation; Adjuvant therapy; Adjuvant treatment; Angiogenesis; Apoptosis; Cancer; Cancer therapies; Cell cycle; Chemotherapy; Chinese medicine; Combination therapy; Cyclophosphamide; Doxorubicin; Drug resistance; Drug resistance in microorganisms; Health aspects; Hepatitis; Hepatocellular carcinoma; Hepatoma; Immunotherapy; Intervention; Kinases; Liver cancer; Liver diseases; Medical prognosis; Medical research; Medicine, Chinese; Medicine, Experimental; Metastasis; Mitomycin C; Molecular targeted therapy; Patients; Prognosis; Review; Side effects; Toxicity; Traditional Chinese medicine; Tumors; Type 2 diabetes; Vascular endothelial growth factor; China
• ISSN: 1749-8546; 1749-8546
• DOI: 10.1186/s13020-022-00645-0

Hepatocellular carcinoma (HCC, accounting for 90% of primary liver cancer) was the sixth most common cancer in the world and the third leading cause of cancer death in 2020. The number of new HCC patients in China accounted for nearly half of that in the world. HCC was of occult and complex onset, with poor prognosis. Clinically, at least 15% of patients with HCC had strong side effects of interventional therapy (IT) and have poor sensitivity to chemotherapy and targeted therapy. Traditional Chinese medicine (TCM), as a multi-target adjuvant therapy, had been shown to play an active anti-tumor role in many previous studies. This review systematically summarized the role of TCM combined with clinically commonly used drugs for the treatment of HCC (including mitomycin C, cyclophosphamide, doxorubicin, 5-fluorouracil, sorafenib, etc.) in the past basic research, and summarized the efficacy of TCM combined with surgery, IT and conventional therapy (CT) in clinical research. It was found that TCM, as an adjuvant treatment, played many roles in the treatment of HCC, including enhancing the tumor inhibition, reducing toxic and side effects, improving chemosensitivity and prolonging survival time of patients. This review summarized the advantages of integrated traditional Chinese and modern medicine in the treatment of HCC and provides a theoretical basis for clinical research. Keywords: Traditional Chinese medicine, Hepatocellular carcinoma, Combination therapy, Adjuvant therapy, Chemotherapy, Molecular targeted therapy, Multidrug resistance, Apoptosis, Antitumor, Overall survival